Membrane Protein Doppelgangers

Courtesy of Declan Doyle  THE POTASSIUM TURNPIKE: KirBac1.1 in a membrane of a cell (green) ready to conduct potassium ions (yellow). Until recently, little progress has been made in determining high-resolution structural data for membrane proteins--the transporters, channels, and receptors that play critical roles in cell physiology. Now, scientists say they might be seeing the trickle that precedes the deluge. The current explosion of genomic information has led to the identification o

Written byMegan Stephan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Until recently, little progress has been made in determining high-resolution structural data for membrane proteins--the transporters, channels, and receptors that play critical roles in cell physiology. Now, scientists say they might be seeing the trickle that precedes the deluge. The current explosion of genomic information has led to the identification of prokaryotic homologs for many eukaryotic transporters and channels. These prokaryotic counterparts offer distinct advantages for crystallization, both in their diversity and ease of production. And while not every feature can be extrapolated to eukaryotes, the results could fill a few gaps in knowledge.

"Membrane protein structure determination is taking off," writes Declan Doyle, University of Oxford, in an E-mail. Doyle and his group have solved the structure of the KirBac1.1 potassium channel from Burkholderia pseudomallei.1 This so-called inwardly rectifying channel protein allows unidirectional flow of potassium ions into cells, and it represents an important advance, says Doyle. "We have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies